Lv32
330 积分 2022-10-13 加入
RYK is a GPNMB receptor that drives MASH
1天前
待确认
Expansion of human hepatocytes and their application in three-dimensional culture and genetic manipulation
11天前
已完结
Dietary supplement Forskolin improves MASLD through hepatocyte-macrophage crosstalk via the GLUT1/ABCF1-HNF4α axis
2个月前
已完结
Scavenger receptor class F member 2 is an intracellular receptor for hepatitis B virus
3个月前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
4个月前
已完结
Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma
4个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
4个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
4个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
4个月前
已完结
p16 Ink4a ‐Positive Hepatocytes Drive Liver Fibrosis Through Activation of LIFR Family Pathway
5个月前
已完结
皖公网安备34019202002308
